We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

837 hedge funds and large institutions have $13.3B invested in Quest Diagnostics in 2024 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 277 increasing their positions, 300 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more call options, than puts

Call options by funds: $92.2M | Put options by funds: $39.9M

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

53% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 59

2% more funds holding

Funds holding: 818 → 837 (+19)

1% more capital invested

Capital invested by funds: $13.2B → $13.3B (+$134M)

8% less repeat investments, than reductions

Existing positions increased: 277 | Existing positions reduced: 300

2.03% less ownership

Funds ownership: 89.74% → 87.71% (-2%)

Holders
837
Holders Change
+19
Holders Change %
+2.32%
% of All Funds
12.09%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
90
Increased
277
Reduced
300
Closed
59
Calls
$92.2M
Puts
$39.9M
Net Calls
+$52.3M
Net Calls Change
-$27.8M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$139M
2
Millennium Management
Millennium Management
New York
+$109M
3
WP
Woodline Partners
California
+$89.2M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$53.8M
5
VLKIM
Van Lanschot Kempen Investment Management
Netherlands
+$48.8M

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$140M
2
NI
Nuance Investments
Missouri
-$90.7M
3
Bessemer Group
Bessemer Group
New Jersey
-$90.2M
4
BlackRock
BlackRock
New York
-$87.8M
5
Marshall Wace
Marshall Wace
United Kingdom
-$54.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
WIA
801
Wetzel Investment Advisors
Indiana
$3.73K – – –
BBHC
802
Brown Brothers Harriman & Co
New York
$3.56K – – –
GG
803
Gleason Group
Kentucky
$3.56K +$3.56K +26 New
LSA
804
Leonteq Securities AG
Switzerland
$3.42K -$411 -3 -11%
AAP
805
Arax Advisory Partners
Colorado
$3.42K +$3.42K +25 New
ANBT
806
American National Bank & Trust
Texas
$3.15K +$3.15K +23 New
KFS
807
Kelly Financial Services
Massachusetts
$3.01K – – –
LIA
808
Lynx Investment Advisory
District of Columbia
$2.9K +$2.88K +21 New
SIC
809
SJS Investment Consulting
Ohio
$2.88K – – –
CWP
810
Concord Wealth Partners
Virginia
$2.46K – – –
RWM
811
Ruedi Wealth Management
Illinois
$2.46K +$2.46K +18 New
DPW
812
DiNuzzo Private Wealth
Pennsylvania
$2.19K +$274 +2 +14%
ATC
813
Adirondack Trust Company
New York
$2.19K – – –
JFA
814
JNBA Financial Advisors
Minnesota
$2.05K – – –
BWAM
815
Boyd Watterson Asset Management
Ohio
$1.78K – – –
ECM
816
Everence Capital Management
Indiana
$1.63K -$422K -3,080 -21%
LTI
817
Laffer Tengler Investments
Tennessee
$1.51K – – –
AP
818
Aspect Partners
Virginia
$1.51K – – –
VWA
819
Valued Wealth Advisors
Utah
$1.51K – – –
BFPW
820
BOK Financial Private Wealth
Colorado
$1.37K – – –
JGIA
821
Jackson Grant Investment Advisers
Connecticut
$1.23K – – –
SC
822
Solstein Capital
California
$1.23K – – –
LCM
823
Logan Capital Management
Pennsylvania
$1.09K +$1.1K +8 New
PCM
824
Penserra Capital Management
California
$1K – – –
Lazard Asset Management
825
Lazard Asset Management
New York
$1K +$1.78K +13 New
31 32
33
34 35

DGX Hedge Fund Activity: Q2 2024 in Review

837 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2024, worth a combined $13.3B — up 1% from $13.2B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new DGX positions and 59 closed out — a net gain of 31 holders — while 277 added to existing stakes and 300 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $139M. The largest seller was American Century Companies, cutting an estimated $140M.

  • 837 institutional investors held Quest Diagnostics (DGX) as of Q2 2024, up from 818 in Q1 2024.
  • Funds reported $13.3B of Quest Diagnostics stock for Q2 2024, up 1% quarter-over-quarter.
  • 90 funds opened new Quest Diagnostics positions in Q2 2024 and 59 closed out, a net change of +31 holders.
  • The largest Quest Diagnostics buyer in Q2 2024 was Citadel Advisors, an estimated $139M added.
  • The largest Quest Diagnostics seller in Q2 2024 was American Century Companies, an estimated $140M sold.

Based on aggregated 13F filings for Q2 2024.